Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.

导出 LinkOut

翻译打印收藏纠错

作者： Lisa,Göschl ^[1] ; Daniel,Mrak ^[1] ; Katharina,Grabmeier-Pfistershammer ^[2] ; Karin,Stiasny ^[3] ; Helmuth,Haslacher ^[4] ; Lisa,Schneider ^[5] ; Thomas,Deimel ^[1] ; Felix,Kartnig ^[1] ; Selma,Tobudic ^[5] ; Daniel,Aletaha ^[1] ; Heinz,Burgmann ^[5] ; Michael,Bonelli ^[1] ; Winfried F,Pickl ^[2] ; Elisabeth,Förster-Waldl ^[6] ; Clemens,Scheinecker ^[1] ; Matthias Gerhard,Vossen ^[5]

作者单位： Division of Rheumatology, University Clinics of Internal Medicine III, Medical University of Vienna, Vienna, Austria. ^[1] Institute of Immunology, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. ^[2] Center for Virology, Medical University of Vienna, Vienna, Austria. ^[3] Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. ^[4] Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria. ^[5] Division of Neonatology, Pediatric Intensive Care and Neuropediatrics with Centre for Congenital Immunodeficiencies & Jeffrey Modell Center Vienna, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. ^[6]

关键词 B-lymphocytes COVID-19 T-lymphocites autoimmune diseases vaccination

主题词抗体, 病毒(Antibodies, Viral);人类(Humans);干扰素γ(Interferon-gamma);甘露糖结合外源凝集素(Mannose-Binding Lectin);接种(Vaccination)

DOI 10.3389/fimmu.2022.974987

PMID 36189225

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交